ZA9810463B - Porous inorganic particles as carriers for drug substances - Google Patents

Porous inorganic particles as carriers for drug substances

Info

Publication number
ZA9810463B
ZA9810463B ZA9810463A ZA9810463A ZA9810463B ZA 9810463 B ZA9810463 B ZA 9810463B ZA 9810463 A ZA9810463 A ZA 9810463A ZA 9810463 A ZA9810463 A ZA 9810463A ZA 9810463 B ZA9810463 B ZA 9810463B
Authority
ZA
South Africa
Prior art keywords
carriers
inorganic particles
porous inorganic
drug substances
drug
Prior art date
Application number
ZA9810463A
Other languages
English (en)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soederbom
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9810463B publication Critical patent/ZA9810463B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9810463A 1997-11-28 1998-11-16 Porous inorganic particles as carriers for drug substances ZA9810463B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704400A SE9704400D0 (sv) 1997-11-28 1997-11-28 Porous inorganic particles as carriers for drug substances

Publications (1)

Publication Number Publication Date
ZA9810463B true ZA9810463B (en) 1999-05-21

Family

ID=20409177

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810463A ZA9810463B (en) 1997-11-28 1998-11-16 Porous inorganic particles as carriers for drug substances

Country Status (26)

Country Link
US (1) US6558703B1 (xx)
EP (1) EP1032370B1 (xx)
JP (1) JP2001524513A (xx)
KR (1) KR20010032557A (xx)
CN (1) CN1280492A (xx)
AR (1) AR016683A1 (xx)
AT (1) ATE256453T1 (xx)
AU (1) AU752044B2 (xx)
BR (1) BR9814751A (xx)
CA (1) CA2311780A1 (xx)
DE (1) DE69820674T2 (xx)
DK (1) DK1032370T3 (xx)
ES (1) ES2210840T3 (xx)
HU (1) HUP0100303A3 (xx)
ID (1) ID24700A (xx)
IL (1) IL136146A0 (xx)
NO (1) NO20002719L (xx)
NZ (1) NZ504353A (xx)
PL (1) PL340927A1 (xx)
PT (1) PT1032370E (xx)
RU (1) RU2219907C2 (xx)
SE (1) SE9704400D0 (xx)
SK (1) SK6602000A3 (xx)
TW (1) TW524694B (xx)
WO (1) WO1999027912A1 (xx)
ZA (1) ZA9810463B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924334D0 (en) * 1999-10-15 1999-12-15 Secr Defence Pharmaceutical products and methods of fabrication therefor
CN100450483C (zh) * 2000-04-11 2009-01-14 三共株式会社 含有钙阻滞剂的稳定药物组合物
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
KR101207553B1 (ko) 2005-06-02 2012-12-03 (주)씨앤팜 금속 이중층 수산화물을 포함하는 생체 주사제용 약물 담체
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
JP5027410B2 (ja) * 2005-12-13 2012-09-19 株式会社サンギ ユビキノン含有組成物
US8287914B2 (en) * 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
GB0909460D0 (en) 2009-06-02 2009-07-15 Intrinsiq Materials Global Ltd Mesoporus material
ES2908958T3 (es) 2013-02-01 2022-05-04 Grace W R & Co Gel de sílice porosa como portador para tecnologías líquidas
AU2014322985B2 (en) * 2013-09-20 2019-05-16 Tillotts Pharma Ag Delayed release pharmaceutical formulation
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
GB8713263D0 (en) 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
EP0376331A3 (en) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
NL9100105A (nl) * 1991-01-23 1992-08-17 Kuil R A Holding Voedingssupplement.
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
US5947893A (en) * 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein

Also Published As

Publication number Publication date
ID24700A (id) 2000-08-03
AU752044B2 (en) 2002-09-05
EP1032370B1 (en) 2003-12-17
WO1999027912A1 (en) 1999-06-10
ES2210840T3 (es) 2004-07-01
US6558703B1 (en) 2003-05-06
AU1356399A (en) 1999-06-16
IL136146A0 (en) 2001-05-20
CN1280492A (zh) 2001-01-17
NZ504353A (en) 2001-10-26
SK6602000A3 (en) 2001-01-18
DK1032370T3 (da) 2004-03-15
DE69820674T2 (de) 2004-09-30
JP2001524513A (ja) 2001-12-04
EP1032370A1 (en) 2000-09-06
BR9814751A (pt) 2000-10-03
HUP0100303A2 (hu) 2001-08-28
SE9704400D0 (sv) 1997-11-28
PT1032370E (pt) 2004-05-31
NO20002719L (no) 2000-07-28
TW524694B (en) 2003-03-21
NO20002719D0 (no) 2000-05-26
DE69820674D1 (de) 2004-01-29
RU2219907C2 (ru) 2003-12-27
KR20010032557A (ko) 2001-04-25
HUP0100303A3 (en) 2004-03-29
CA2311780A1 (en) 1999-06-10
PL340927A1 (en) 2001-03-12
AR016683A1 (es) 2001-07-25
ATE256453T1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
SG93898A1 (en) Porous materials
EG21958A (en) Microstructured filter
PL340337A1 (en) Drugs
IL115912A0 (en) Pharmaceutical carrier
PL339864A1 (en) Preparation containing 2-methylthiene benzodiazepin
GB9700504D0 (en) Pharmaceutical compounds
HUP0103666A3 (en) Porous polymer particles
ZA9810463B (en) Porous inorganic particles as carriers for drug substances
GB2336793B (en) Filter Media
EP1003495A4 (en) PHARMACEUTICAL COMPOUNDS
GB9716244D0 (en) Pharmaceutical compounds
GB9706195D0 (en) Particulate drug carriers
GB9722031D0 (en) Identifiable substances
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9614849D0 (en) Processes for the scubbing of noxious substances
GB9704339D0 (en) Particulate material
HUP0202652A3 (en) Pharmaceutical carrier composition
GB2327048B (en) Adsorbent materials
AU8228698A (en) Porous container
GB9700895D0 (en) Pharmaceutical compounds
GB2330382B (en) Container for illegal drugs
SI1032370T1 (en) Porous hydroxyapatite particles as carriers for drug substances
ZA985361B (en) Particulate material separation
TW362715U (en) Improved structure for air filter
GB9715825D0 (en) Porous solid products